Duska Franic, Pharm.D., Ph.D.
- Office: R.C. Wilson , Rm 260N Athens, GA 30602USA
- Voice: 706-542-1132
- Fax: 706-542-5228
- Email: email@example.com
Ph.D. , Ohio State University 2000
M.S. , Ohio State University 1997
Pharm.D. , Philadelphia College of Pharmacy and Science 1995
Graduate Diploma in Hospital Pharmacy , Victorian College of Pharmacy 1992
B.Pharm , Victorian College of Pharmacy 1988
My research program focus lies in patient reported outcomes (PROs). My research interest initiated with patient outcomes in pharmaceutical care utilizing survey research design. This has expanded to include behavioral decision making in addition to health related quality of life. My research program has focused on methodological issues surrounding various methods of patient preference measurement including psychometric and non-psychometric, or welfare based approaches, including utility assessment and contingent valuation, with an emphasis on policy decision making.
Pharmacia and Upjohn Graduate Fellowship Award, 2000.
Presented Fostering interdisciplinary professionalism through collaborative teaching at 1st COE Innovation in teaching conference, UGA Conference Center for CE. Athens GA October 17, 2014
Franic DM, Snapp C, DeBusk R, Krishnamoorthy, N. Construct validity of two commonly used functional medicine instruments: Five Facet Mindfulness Questionnaire and Medical Symptoms Questionnaire. Quality of Life Research 2012;21(Suppl 1):91
Franic DM, Snapp C, DeBusk R. Newly developed functional medicine program in diabetes: impact on clinical and patient reported outcomes - functional medicine and quality of life. BMC Complementary and Alternative Medicine 2012, 12(Suppl 1), 18.
Kangethe A, Franic DM, Corso P, Southwood R. Cost-benefit analysis of a diabetes prevention program in rural Kenya. Value in Health 2012;15(4): A179.
Kangethe A, Franic DM. Value of a diabetes prevention program in rural Kenya: comparing payment card and structured haggling willingness to pay methods. Value in Health 2012;15(4): A185.
Franic DM, Bothe A, Bramlett R. Assessment of respondent acceptability for preference measures in stuttering. Journal of Communication Disorders 2012, 45(12): 378-389. http://dx.doi.org/10.1016/j.jcomdis.2012.05.001
Franic DM, Bothe A, Bramlett R. A welfare economic approach to measuring outcomes: comparing the willingness to pay and quality adjusted life years. Journal of Fluency Disorders 2012, 37; 300 – 313. http://dx.doi.org/10.1016/j.jfludis.2012.04.005
Franic DM, Kleyman K. A qualitative study of herbal medicine use in the Ukraine: Implications for US pharmacy practice. Journal of Pharmacy Practice 2012;25(1): 100-104. doi: 10.1177/0897190011431633. (co-author is a PharmD student)
Kangethe A, Franic DM, Huang M, Huston S, Williams C. US Publication trends in social and administrative pharmacy: implications for promotion and tenure. Research in Social and Administrative Pharmacy 2012; 8(5): 408 – 419. http://dx.doi.org/10.1016/j.sapharm.2011.10.002
Kangethe A, Franic, DM. A review and classification of the literature of contingent valuation method studies in sub-Sahara Africa. Value in Health 2011;14(3): A146.
Franic DM, Tootle-Tucker L, Haddock SM. Pharmaceutical care: what's in a name? A qualitative analysis of patient perceptions of pharmacy practice. Journal of Pharmacy Technology 2008; 24(4): 191-201.
Franic DM, Bothe AK. Patient reported outcomes in stuttering treatment: conceptual framework. Expert Review of Pharmacoeconomics and Outcomes Research 2008;8(2):127-131.
Bothe AK, Franic DM, Ingham RJ, Davidow JH. Pharmacological Approaches to Stuttering Treatment: Reply to Meline and Harn (2008). American Journal of Speech-Language & Pathology,2008;17: 98-101.
Franic DM, Bothe A. Psychometric Evaluation of Condition-Specific Instruments Used To Assess Health-Related Quality of Life, Attitudes, and Related Constructs in Stuttering American Journal of Speech-Language and Pathology 2008;17: 60-80.
Franic DM, Haddock SM, Tootle-Tucker L, Wooten N. Pharmacy patronage: Identifying key factors in the decision making process using the determinant attribute approach. Journal of the American Pharmacists Association 2008; 48(1): 71-85.
Franic DM, Jiang J. Inappropriate medication use results in poor quality of life in the elderly: a retrospective study, Pharmacotherapy 2006; 26(6):768 - 778.
Bothe AK, Davidow JH, Bramlett RE, Franic DM, Ingham RJ,. Stuttering Treatment Research, 1970 – 2005: II. Systematic Review Incorporating Trial Quality Assessment of Pharmacological Approaches. American Journal of Speech-Language Pathology 2006; 15(4): 342 - 352.
Bramlett R, Bothe A, Franic DM. Using Preference-Based Measures to Assess Quality of Life in Stuttering. Journal of Speech, Language, and Hearing Research 2006(49): 381-394.
Franic DM, Grauer D, Law A. An Evaluation of Patients' Attitudes toward Pharmacy Selection: a Determinant Attribute Approach. Journal of Pharmaceutical Marketing and Management 2005; 17(1):35-50.
Franic DM, Aull L, Grauer D, Oyelowo OO. The association between adherence, asthma control, generic and disease specific quality of life instruments in asthma. Expert Review of Pharmacoeconomics & Outcomes Research 2005; 5(4):411-422.
Franic DM, Pathak DS, Gafni A. Relating quality adjusted life years to contingent valuation in oncology: acute versus chronic illnesses. Journal of Clinical Epidemiology 2005;58(3):291-303.
Franic DM, Bramlett R, Bothe A. Psychometric evaluation of disease specific quality of life instruments in voice disorders. Journal of Voice 2005;19(2):300-315.
Franic DM. Promoting learning in a health care systems course by multiple testing methods including internet-based quizzes. American Journal of Pharmaceutical Education.2004;68(5): Article 119.
Deshpande A, Wade W, Johnson T, Franic DM. A survey of pharmacy student involvement in wellness programs. American Journal of Pharmaceutical Education.2004;68(5) Article 122.
Franic DM, Pathak D, Kwong J, Pierson J. Cost Utility Analysis. In:. Pharmacoeconomics and Outcomes:. Grauer D, Lee T, Odom J, Osterhaus L, Sanchez L, Touchette D. eds. 2nd Ed. American College of Clinical Pharmacy, 2003, pp146 – 181.
Franic DM. Cost Utility Analysis Case study. In: Pharmacoeconomics and Outcomes: Case Studies. Grauer D, Lee T, Odom J, Osterhaus L, Sanchez L, Touchette D. eds. 2nd Ed. American College of Clinical Pharmacy, 2003, pp16-20.
Franic DM, Pathak DS. Respondents' Attitude Toward Preference Measurement Tools: Graphic Positioning Scale Versus Traditional Scales. Value in Health 2003; 6(4): 483-493.
Franic DM, Pathak DS. Effect of including (versus excluding) fates worse than death in utility assessment. International Journal of Technology Assessment in Health Care 2003; 19(2): 346 – 360.
Franic DM, Pathak DS, Gafni A. Are Health States “Timeless”: A Case Study Of An Acute Condition - Post Chemotherapy Nausea And Vomiting. Journal of Evaluation in Clinical Practice 2003; 9(1): 69-82.
Franic DM, Pathak DS. Communicating the frequency of adverse drug reactions to female patients. Drug Information Journal 2000;34(1):1-22.